Participate in the Champions Oncology PDX Indication Screen for Lower cost, Large-scale PDX Pharmacology Studies

50 Clinically Relevant PDX Models

Click here to View Additional Characterization Data
Pancreatic, Colorectal & Sarcoma

Enrollment Open Now – February 28th 
Models available on a first-come, first-served basis

Free FFPE/Snap frozen samples available at no cost for target validation

NGS Data (WES and RNASeq) is freely available for all models
Free FFPE/Snap frozen samples available at no cost for target validation

ENROLLMENT OPEN NOW THROUGH FEBRUARY 28TH

  • Significant cost savings compared to stand-alone studies
  • No minimum enrollment
  • Free terminal tumor collections (snap frozen/FFPE)
  • FREE SOC ex vivo/in vitro response will be provided for each model.
  • Flow cytometry, IHC, and Nanostring gene expression analysis available
  • Enrollment period ends February 28th, 2020  

Available on a first-come, first-serve basis

Contact us today to enroll in this screen.